Dr Reddys Laboratories (RDY) Interest Coverage Ratio Growth (3y) (2012 - 2013)
Dr Reddys Laboratories (RDY) Interest Coverage Ratio Growth (3y) (2012 - 2013) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.09 Bn | 7.44 Bn | 397.90 Mn | -75.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 13.93% |
| Dec 31, 2012 | 6,756.09% |